Last updated on April 19, 2014 at 9:20 EDT

Latest Saegis Pharmaceuticals Inc. Stories

2005-06-09 18:39:02

An experimental drug combined with an already-popular memory-enhancing compound may further delay memory loss in patients with Alzheimer's disease and other dementias, Johns Hopkins University scientists, in collaboration with researchers from University of North Carolina, have found. The findings, described in the June issue of Neuropsychopharmacology, also indicate that the experimental treatment in question "“ a compound known as SGS742 "“ works by blocking certain chemicals...